查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604497

远端过敏管理中人工智慧 (AI) 的全球市场：预测（2024-2029 年）

Artificial Intelligence (AI) In Remote Allergy Management Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球人工智慧（AI）远端过敏管理市场规模预计将以 34.54% 的复合年增长率成长，从 2024 年的 1,580,089,000 美元市场规模到 2029 年达到 6,965,727,000 美元。

远端过敏管理市场中的人工智慧是一个前沿且快速成长的行业，利用人工智慧（AI）和数位技术彻底改变过敏监测和治疗。由于世界各地的人们都受到过敏的影响，因此需要可以远端管理的个人化治疗。如今，凭藉所有可用的资源和行动设备，消费者足不出户即可有效控制和应对过敏。这些系统融合了即时症状追踪、治疗通讯协定客製化以及与医生的视讯会议等先进功能。

利用 AI Smarts 进行远距过敏治疗有望透过提高不必要的患者依从性、增加患者获得专业服务的机会以及降低医疗成本来改善客户治疗效果。越来越多的患者加入远端医疗、改进人工智慧演算法以及对有效和预防性过敏管理的需求不断增加，是推动人工智慧在远距过敏管理市场扩张的主要因素。

远端过敏管理市场中的人工智慧 (AI) 驱动因素：

  • 过敏盛行率的增加将推动人工智慧在远端过敏管理市场的成长

过敏盛行率的上升是远端过敏管理市场人工智慧成长的主要驱动力。过敏影响着世界各地的许多人，这产生了对新的、更好的治疗方法的需求。支持者指出环境因素、生活方式的改变和遗传倾向是过敏的主要原因。过敏症盛行率的不断上升大大增加了对远距医疗保健系统的需求，该系统可以为过敏患者提供个人化和即时的护理。人工智慧驱动的平台能够处理巨量资料，包括过敏原暴露、体征和症状以及治疗效果等因素，即使对于遥远的患者也能进行更好的过敏管理。

远端过敏管理人工智慧（AI）市场的地域展望

  • 北美在预测期内将经历指数级增长

北美处于采用新型医疗保健技术的最前沿，例如人工智慧驱动的过敏治疗系统。由于该地区过敏发生率较高，因此非常重视扩大远端医疗和数位健康平台。

此外，北美拥有强大的医疗基础设施、越来越多的专门从事人工智慧的公司以及大量的研发投资。重要企业的存在以及IT企业与医疗机构之间的合作正在进一步推动人工智慧在该地区远距过敏管理市场的扩张。在技​​术改进和远距医疗需求不断增长的推动下，北美地区透过人工智慧主导的解决方案继续引领过敏管理转型。

为什么要购买这份报告？

  • 富有洞察力的分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、行业和其他子区隔。
  • 竞争格局：了解世界主要企业采取的策略策略，并了解透过正确的策略渗透市场的潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何塑造未来市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中发现新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业有用且具有成本效益。

它有什么用？

产业与市场考量、商机评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022年至2029年的过往资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略和市场占有率分析
  • 区域收益成长和预测分析，包括细分市场和国家
  • 公司简介（主要是策略、产品、财务资讯、主要动态等）

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章远端过敏管理中的人工智慧（AI）市场：按产品类型

  • 介绍
  • 行动应用程式
  • 穿戴式装置
  • 远端医疗平台
  • 其他的

第六章远端过敏管理中的人工智慧（AI）市场：按应用分类

  • 介绍
  • 过敏测试和诊断
  • 过敏原免疫治疗管理
  • 症状监测和管理
  • 用药管理
  • 其他的

第七章 远端过敏管理中的人工智慧 (AI) 市场：按最终用户分类

  • 介绍
  • 医院和诊所
  • 过敏诊所和中心
  • 研究所
  • 病人（直销）
  • 其他的

第八章远端过敏管理中的人工智慧（AI）市场：按地区

  • 介绍
  • 北美洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 依产品类型
    • 按用途
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 併购/协议/合作
  • 竞争对手仪表板

第十章 公司简介

  • K Health, Inc.
  • Health Navigator
  • Buoy Health, Inc.
  • Ada Health Gmbh
  • Sensely, Inc.
  • Your.Md
  • Infermedica
  • Mediktor, SL
  • 98point6 Inc.
  • Babylon Health
简介目录
Product Code: KSI061615855

The Artificial Intelligence (AI) in remote allergy management market is expected to grow at a CAGR of 34.54%, reaching a market size of US$6,965.727 million in 2029 from US$1,580.089 million in 2024.

AI in the remote allergy management market is a cutting-edge and fast-rising industry that uses artificial intelligence (AI) and digital technology to revolutionize allergy monitoring and treatment. People worldwide are being affected by allergies, thus making it necessary to have manageable individualized treatment from a distance. Nowadays, all resources and portable devices allow consumers to effectively control and deal with their allergies without stepping out of the house. These systems incorporate advanced features such as tracking symptoms in real-time, customization of treatment protocols, and video conferencing with doctors.

AI Smarts remote allergic treatments promise to enhance clients' results by improving undesirable patient compliance, providing better patient access to specialized services, and reducing healthcare costs. The growing number of patients enrolling in telemedicine, improving AI algorithms, and increasing demand for effective and proactive management of allergies are the major factors contributing to AI in the remote allergy management market's expansion.

Artificial intelligence (AI) in remote allergy management market drivers:

  • The increasing prevalence of allergies enhances the AI in remote allergy management market growth.

The rising incidence of allergies is a major driver of growth in AI in the remote allergy management market. Allergies affect many individuals worldwide, thus creating a demand for new and better treatment methods. Proponents point to environmental factors, lifestyle changes, and genetic make-up as the key reasons for the increasing number of allergies. Given the increasing prevalence of allergies, there is a burgeoning need for a remote healthcare system able to offer patients with allergies individualized and real-time care. Powered by AI, the platforms are capable of processing big data that include factors such as exposure to allergens, signs and symptoms, and treatment efficacy in enhanced management of allergies, even for patients who are far away.

Artificial Intelligence (AI) in Remote Allergy Management Market Geographical Outlook

  • North America is witnessing exponential growth during the forecast period

North America is at the forefront of embracing novel healthcare technology, such as AI-powered allergy treatment systems. There is a significant frequency of allergies in the region and a great emphasis on expanding telemedicine and digital health platforms.

Furthermore, North America has a strong healthcare infrastructure, a rising number of AI-focused firms, and considerable investment in R&D. The presence of significant players and cooperation between IT businesses and healthcare institutions push AI in remote allergy management market expansion in this area even further. North America continues to lead in revolutionizing allergy management with AI-driven solutions, thanks to technological improvements and rising demand for remote healthcare.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2029
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Artificial Intelligence (AI) in remote allergy management market is segmented and analyzed as follows:

By Product Type

  • Mobile Apps
  • Wearable Devices
  • Telemedicine Platforms
  • Others

By Application

  • Allergy Testing and Diagnosis
  • Allergen Immunotherapy Management
  • Symptom Monitoring and Management
  • Medication Management
  • Others

By End-User

  • Hospitals And Clinics
  • Allergy Clinics And Centers
  • Research Institutes
  • Patients (Direct-To-Consumer)
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Mobile Apps
  • 5.3. Wearable Devices
  • 5.4. Telemedicine Platforms
  • 5.5. Others

6. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Allergy Testing and Diagnosis
  • 6.3. Allergen Immunotherapy Management
  • 6.4. Symptom Monitoring and Management
  • 6.5. Medication Management
  • 6.6. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals And Clinics
  • 7.3. Allergy Clinics And Centers
  • 7.4. Research Institutes
  • 7.5. Patients (Direct-To-Consumer)
  • 7.6. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN REMOTE ALLERGY MANAGEMENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. BY End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. BY End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. BY End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. BY End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. BY End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. K Health, Inc.
  • 10.2. Health Navigator
  • 10.3. Buoy Health, Inc.
  • 10.4. Ada Health Gmbh
  • 10.5. Sensely, Inc.
  • 10.6. Your.Md
  • 10.7. Infermedica
  • 10.8. Mediktor, S.L.
  • 10.9. 98point6 Inc.
  • 10.10. Babylon Health